Margareta Tempero News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Margareta tempero. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Margareta Tempero Today - Breaking & Trending Today

RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights

Presented positive Phase III TIGeR-PaC interim study results observing 8-month delay in cancer progression, concordant with 6-month overall survival benefit and 65% reduction in adverse effects over. ....

United States , Robertj Spiegel , Shaun Bagai , Margareta Tempero , University Of Texas Southwestern Medical Center , Pancreas Cancer Program , Exchange Commission , Company Board Of Directors , Renovorx Inc , World Congress , Securities Exchange , Company Nasdaq , American Association For Cancer Research Annual Meeting , Company Scientific Advisory Board , Pancreas Center , Imugene Ltd , Scientific Advisory , Business Highlights , Gastrointestinal Cancer , American Association , Cancer Research Annual , Texas Southwestern Medical Center , Cancer Program , Scientific Advisory Board , Chief Medical Officer , New Drug Application ,

RenovoRx Appoints Margaret A. Tempero, M.D., to Scientific Advisory Board

RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced the appointment of Margaret A. Tempero, M.D., Director, UCSF Pancreas Center. | June 20, 2023 ....

United States , Shaun Bagai , Robert Spiegel , Margareta Tempero , Pancreas Cancer Program , Research Programs , Company Scientific Advisory Board , V Foundation , Scientific Advisory Boards Of The Lustgarten Foundation , Methods In Clinical Cancer Research , Guidelines Panel On Pancreatic Cancer , Cancer Foundation Board , Helen Diller Family Comprehensive Cancer Center , Division Of Hematology , Company Nasdaq , Schering Plough , Pancreas Center , Oncology Drug Advisory Committee , Pancreatic Cancer Action Network , Renovorx Inc , Division Of Medical Oncology , American Association Of Clinical Research Annual Meeting , Cancer Program , Scientific Advisory Board , Chief Medical Officer , Renovorx Board ,

Adjuvant Combo Boosts Survival in Resected Pancreatic Cancer

email article
Postoperative treatment of pancreatic cancer with nab-paclitaxel (Abraxane) and gemcitabine improved survival by more than 4 months as compared with gemcitabine alone, long-term follow-up from a randomized trial showed.
Median overall survival (OS) was 41.8 months with the combination versus 37.7 months with single-agent gemcitabine. The combination led to a 7% absolute improvement in 5-year OS.
The survival advantage remained consistent across a prespecified subgroup analysis, reported Margaret A. Tempero, MD, of the University of California San Francisco, during the virtual World Congress on Gastrointestinal Cancer. OS was a secondary endpoint of the randomized phase III APACT trial, which did not meet the primary endpoint of disease-free survival (DFS). ....

Charles Bankhead , Margareta Tempero , Thomas Seufferlein , University Of California San Francisco , University Of Ulm , World Congress On Gastrointestinal Cancer , California San Francisco , World Congress , Medpage Today , சார்லஸ் வங்கித் தலை , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா சான் பிரான்சிஸ்கோ , பல்கலைக்கழகம் ஆஃப் அல்ம் , உலகம் காங்கிரஸ் ஆன் இரைப்பை குடல் புற்றுநோய் , கலிஃபோர்னியா சான் பிரான்சிஸ்கோ , உலகம் காங்கிரஸ் ,